<SEC-DOCUMENT>0001047469-16-014500-index.html : 20160728
<SEC-HEADER>0001047469-16-014500.hdr.sgml : 20160728
<ACCEPTANCE-DATETIME>20160727215630
ACCESSION NUMBER:		0001047469-16-014500
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20160728
DATE AS OF CHANGE:		20160727

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-212713
		FILM NUMBER:		161788168

	BUSINESS ADDRESS:	
		STREET 1:		101 PARK DRIVE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		101 PARK DRIVE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RY

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>a2229260zs-3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: a2229260zs-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>a2229260zex-1_2.htm
<DESCRIPTION>EX-1.2
<TEXT>
Document 2 - file: a2229260zex-1_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>a2229260zex-5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: a2229260zex-5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>a2229260zex-23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 4 - file: a2229260zex-23_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g730660.jpg
<DESCRIPTION>G730660.JPG
<TEXT>
Document 5 - file: g730660.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g292820.jpg
<DESCRIPTION>G292820.JPG
<TEXT>
Document 6 - file: g292820.jpg

</DOCUMENT>
</SEC-DOCUMENT>